CoChat

The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?

Open access
Millan, Mark J. · 2014 · Dialogues in Clinical Neuroscience
Cited by 63

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Early-onset, familial Alzheimer's disease (AD) is rare and may be attributed to disease-causinq mutations. By contrast, late onset, sporadic (non-Mendelian) AD is far more prevalent and reflects the interaction of multiple genetic and environmental risk factors, together with the disruption of epigenetic mechanisms controlling gene expression. Accordingly, abnormal patterns of histone acetylation and methylation, as well as anomalies in global and promoter-specific DNA methylation, have been documented in AD patients, together with a deregulation of noncoding RNA. In transgenic mouse models for AD, epigenetic dysfunction is likewise apparent in cerebral tissue, and it has been directly linked to cognitive and behavioral deficits in functional studies. Importantly, epigenetic deregulation interfaces with core pathophysiological processes underlying AD: excess production of Aβ42, aberrant post-translational modification of tau, deficient neurotoxic protein clearance, axonal-synaptic dysfunction, mitochondrial-dependent apoptosis, and cell cycle re-entry. Reciprocally, DNA methylation, histone marks and the levels of diverse species of microRNA are modulated by Aβ42, oxidative stress and neuroinflammation. In conclusion, epigenetic mechanisms are broadly deregulated in AD mainly upstream, but also downstream, of key pathophysiological processes. While some epigenetic shifts oppose the evolution of AD, most appear to drive its progression. Epigenetic changes are of irrefutable importance for AD, but they await further elucidation from the perspectives of pathogenesis, biomarkers and potential treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.31887/dcns.2014.16.3/mmillan

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 139

  1. Reitz C., 2011, Nat Rev Neurol., 7, 137, 10.1038/nrneurol.2011.2 · DOI · Paper page
  2. Adwan L., 2013, Pharmacol Ther., 139, 41, 10.1016/j.pharmthera.2013.03.010 · DOI · Paper page
  3. Anand R., 2014, Neuropharmacology., 76, 27, 10.1016/j.neuropharm.2013.07.004 · DOI · Paper page
  4. Jacobs HI., 2013, Neurosci Biobehav Rev., 37, 753, 10.1016/j.neubiorev.2013.03.009 · DOI
  5. Martin L., 2011, Neurochem Int., 58, 458, 10.1016/j.neuint.2010.12.023 · DOI · Paper page
  6. Khandelwal PJ., 2011, J Neuroimmunol., 238, 1, 10.1016/j.jneuroim.2011.07.002 · DOI · Paper page
  7. Mukhopadhyay S., 2014, Apoptosis., 19, 555, 10.1007/s10495-014-0967-2 · DOI · Paper page
  8. Swiss VA., 2010, Glia., 58, 377, 10.1002/glia.20933 · DOI
  9. Huang Y., 2010, Mol Med., 16, 287, 10.2119/molmed.2009.00165 · DOI
  10. Lambert JC., 2011, Genet Dev., 21, 295, 10.1016/j.gde.2011.02.002 · DOI
  11. Lu H., 2013, Front Aging Neurosci., 5, 85
  12. Mastroeni D., 2011, Neurobiol Aging., 32, 1161, 10.1016/j.neurobiolaging.2010.08.017 · DOI · Paper page
  13. Wang J., 2013, Ageing Res Rev., 12, 1024, 10.1016/j.arr.2013.05.003 · DOI
  14. Bihaqi SW., 2012, Curr Alzheimer Res., 9, 574, 10.2174/156720512800617982 · DOI · Paper page
  15. Bradley-Whitman MA., 2013, Mech Ageing Dev., 134, 486, 10.1016/j.mad.2013.08.005 · DOI · Paper page
  16. Cencioni C., 2013, Int J Mol Sci., 14, 17643, 10.3390/ijms140917643 · DOI · Paper page
  17. Walker MP., 2013, Age (Disorder)., 35, 519, 10.1007/s11357-011-9375-5 · DOI
  18. Deaton AM., 2011, Genes Dev., 25, 1010, 10.1101/gad.2037511 · DOI · Paper page
  19. Grayson DR., 2013, Neuropsychopharmacology., 38, 138, 10.1038/npp.2012.125 · DOI · Paper page
  20. Fleming JL., 2012, Curr Alzheimer Res., 9, 1077, 10.2174/156720512803569000 · DOI
  21. Chouliaras L., 2013, Neurobiol Aging., 34, 2091, 10.1016/j.neurobiolaging.2013.02.021 · DOI · Paper page
  22. Coppieters N., 2014, Neurobiol Aging., 35, 1334, 10.1016/j.neurobiolaging.2013.11.031 · DOI · Paper page
  23. Iwata A., 2014, Hum Mol Genet., 23, 648, 10.1093/hmg/ddt451 · DOI · Paper page
  24. Fuso A., 2012, Curr Alzheimer Res., 9, 527, 10.2174/156720512800618053 · DOI
  25. Fuso A., 2005, Mol Cell Neurosci., 28, 195, 10.1016/j.mcn.2004.09.007 · DOI · Paper page
  26. Guo X., 2011, Neurocience., 194, 272, 10.1016/j.neuroscience.2011.07.012 · DOI
  27. Rao JS., 2012, Transl Psychiatry., 2, e132, 10.1038/tp.2012.55 · DOI · Paper page
  28. Gu X., 2013, Neurobiol Aging., 34, 1069, 10.1016/j.neurobiolaging.2012.10.013 · DOI
  29. Chen KL., 2009, Biochem Biophys Res Commun., 378, 57, 10.1016/j.bbrc.2008.10.173 · DOI
  30. Taher N., 2014, J Alzheimers Dis., 38, 831, 10.3233/JAD-131061 · DOI
  31. Van den Hove DL., 2014, Neurobiol Aging., 35, 731, 10.1016/j.neurobiolaging.2013.10.082 · DOI
  32. Xu B., 2012, Neurobiol Dis., 46, 291, 10.1016/j.nbd.2012.02.016 · DOI · Paper page
  33. Sun G., 2011, Nat Commun., 2, 529, 10.1038/ncomms1532 · DOI · Paper page
  34. Li X., 2013, Neurobiol Learn Mem., 105, 125, 10.1016/j.nlm.2013.06.009 · DOI
  35. Kouzarides T., 2007, Cell., 128, 693, 10.1016/j.cell.2007.02.005 · DOI · Paper page
  36. Day JJ., 2011, Neuron., 70, 813, 10.1016/j.neuron.2011.05.019 · DOI · Paper page
  37. Jarome TJ., 2013, Rev Neurosci., 24, 375, 10.1515/revneuro-2013-0008 · DOI · Paper page
  38. Zhang K., 2012, Proteomics., 12, 1261, 10.1002/pmic.201200010 · DOI · Paper page
  39. Francis Yl., 2009, J Alzheimers Dis., 18, 131, 10.3233/JAD-2009-1134 · DOI · Paper page
  40. Zhang ZY., 2013, J Neuropathol Exp Neurol., 72, 178, 10.1097/NEN.0b013e318283114a · DOI · Paper page
  41. Bie B., 2014, Nat Neurosci., 17, 223, 10.1038/nn.3618 · DOI
  42. Lithner CU., 2013, Neurobiol Aging., 34, 2081, 10.1016/j.neurobiolaging.2012.12.028 · DOI
  43. Wang Z., PLoS One., 6, e19229, 10.1371/journal.pone.0019229 · DOI · Paper page
  44. Barry G., 2014, Mol Psychiatry., 19, 410, 10.1038/mp.2013.196 · DOI
  45. Bartel, 2009, Cell., 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
  46. Bernstein BE., 2012, Nature., 489, 57, 10.1038/nature11247 · DOI · Paper page
  47. Qureshi IA., 2013, Neurotherapeutics., 10, 632, 10.1007/s13311-013-0199-0 · DOI
  48. Millan MJ., 2011, Curr Opin Pharmacol., 11, 11, 10.1016/j.coph.2011.01.008 · DOI
  49. Goodall EF., 2013, Front Cell Neurosci., 7, 178, 10.3389/fncel.2013.00178 · DOI · Paper page
  50. Lau P., 2014, Ageing Res Rev., 17G43
  51. Satoh J., 2012, Exp Neurol., 235, 436, 10.1016/j.expneurol.2011.09.003 · DOI
  52. Long JM., 2012, Exp Neurol., 235, 402, 10.1016/j.expneurol.2011.12.043 · DOI · Paper page
  53. Lukiw WJ., 2007, Neuroreport., 18, 297, 10.1097/WNR.0b013e3280148e8b · DOI · Paper page
  54. Müller M., 2014, Neurobiol Aging., 35, 152, 10.1016/j.neurobiolaging.2013.07.005 · DOI · Paper page
  55. Chai S., 2013, Proc Natl Acad Sci U S A., 110, 17898, 10.1073/pnas.1317528110 · DOI
  56. Lau P., 2013, EMBO Mol Med., 5, 1613, 10.1002/emmm.201201974 · DOI · Paper page
  57. Smith PY., 2011, Hum Mol Genet., 20, 4016, 10.1093/hmg/ddr330 · DOI · Paper page
  58. Smith P., 2011, J Neurochem., 116, 240, 10.1111/j.1471-4159.2010.07097.x · DOI · Paper page
  59. Wang WX., 2008, J Neurosci., 28, 1213, 10.1523/JNEUROSCI.5065-07.2008 · DOI · Paper page
  60. Schonrock N., 2012, J Mol Neurosci., 46, 324, 10.1007/s12031-011-9587-2 · DOI · Paper page
  61. Nunez-lglesias J., 2010, PLoS One., 5, e8898, 10.1371/journal.pone.0008898 · DOI · Paper page
  62. Persengiev S., 2011, Neurobiol Aging., 32, 2316e17, 10.1016/j.neurobiolaging.2010.03.014 · DOI
  63. Shioya M., 2010, Neuropathol Appl Neurobioi., 36, 320, 10.1111/j.1365-2990.2010.01076.x · DOI · Paper page
  64. Geekiyanage H., 2012, Exp Neurol., 235, 491, 10.1016/j.expneurol.2011.11.026 · DOI · Paper page
  65. Braidy N., 2012, Curr Opin Psychiatry., 25, 226, 10.1097/YCO.0b013e32835112c1 · DOI · Paper page
  66. Min SW., 2013, Front Aging Neurosci., 5, 1
  67. Moon JM., 2013, J Cereb Blood Flow Metab., 33, 1976, 10.1038/jcbfm.2013.157 · DOI · Paper page
  68. Ouyang YB., 2012, Mitochondrion., 12, 213, 10.1016/j.mito.2011.09.001 · DOI · Paper page
  69. Zhang L., 2012, J Neuroinflammation., 9, 211, 10.1186/1742-2094-9-211 · DOI · Paper page
  70. Barak B., 2013, Transl Psychiatry., 3, e304, 10.1038/tp.2013.77 · DOI · Paper page
  71. Delay C., 2011, Int J Alzheimer's Disease., 894938
  72. Boissoneault V., 2009, J Biol Chem., 284, 1971, 10.1074/jbc.M807530200 · DOI · Paper page
  73. Liu W., 2012, Neurobiol Aging., 33, 522, 10.1016/j.neurobiolaging.2010.04.034 · DOI · Paper page
  74. Zhang R., 2014, mice. J Neurol Sci., 338, 57, 10.1016/j.jns.2013.12.017 · DOI
  75. Caraci F., 2012, Cell Tissue Res., 347, 291, 10.1007/s00441-011-1230-6 · DOI
  76. Li JJ., 2014, PLoS One., 9, e90770, 10.1371/journal.pone.0090770 · DOI
  77. Xu S., 2012, Int J Mol Sci., 13, 16945, 10.3390/ijms131216945 · DOI · Paper page
  78. Chio CC., 2013, Arch Toxicol., 87, 459, 10.1007/s00204-012-0965-5 · DOI
  79. Lukiw WJ., 2013, Front Genet., 3, 327, 10.3389/fgene.2012.00327 · DOI · Paper page
  80. Wang LL., 2012, Med Hypotheses., 78, 398, 10.1016/j.mehy.2011.11.019 · DOI
  81. Boldin MP., 2012, Immunol Rev., 246, 205, 10.1111/j.1600-065X.2011.01089.x · DOI · Paper page
  82. Lukiw WJ., 2012, Mol Neurobiol., 46, 11, 10.1007/s12035-012-8234-4 · DOI · Paper page
  83. Zhao Y., Mol Neurobiol. In press.
  84. Toh H., 2011, J Mol Neurosci., 45, 538, 10.1007/s12031-011-9569-4 · DOI
  85. Wang WX., 2010, Am J Pathol., 177, 334, 10.2353/ajpath.2010.091202 · DOI · Paper page
  86. Lukiw WJ., 2012, Neuroreport., 23, 621
  87. Lehmann SM., 2012, Nat Neurosci., 15, 827, 10.1038/nn.3113 · DOI · Paper page
  88. Hébert SS., 2009, Neurobiol Disease., 33, 422, 10.1016/j.nbd.2008.11.009 · DOI · Paper page
  89. Patel N., 2008, Mol Neurodegen., 3, 10, 10.1186/1750-1326-3-10 · DOI · Paper page
  90. Roshan R., 2012, RNA Biol., 9, 891, 10.4161/rna.19876 · DOI
  91. Faghihi MA., 2010, Genome Biol., 11, R56, 10.1186/gb-2010-11-5-r56 · DOI · Paper page
  92. Fang M., 2012, Toxicol Lett., 209, 94, 10.1016/j.toxlet.2011.11.032 · DOI · Paper page
  93. Zhang C., 2010, J Biol Chem., 285, 8515, 10.1074/jbc.M109.079079 · DOI · Paper page
  94. Augustin R., 2012, BMC Med Genet., 13, 35, 10.1186/1471-2350-13-35 · DOI · Paper page
  95. Cheng C., 2013, J Biol Chem., 288, 13748, 10.1074/jbc.M112.381392 · DOI · Paper page
  96. Xu D., 2009, FASEB J., 23, 3674, 10.1096/fj.09-133462 · DOI · Paper page
  97. Lukiw WJ., 2012, Exp Neurol., 235, 484, 10.1016/j.expneurol.2011.11.022 · DOI · Paper page
  98. Dickson JR., 2013, J Neurochem., 127, 739, 10.1111/jnc.12437 · DOI · Paper page
  99. Hebert SS., 2010, Hum Mol Genet., 19, 3959, 10.1093/hmg/ddq311 · DOI · Paper page
  100. Aranha MM., 2011, PLoS One., 6, e21396, 10.1371/journal.pone.0021396 · DOI · Paper page
  101. Im HI., 2012, Trends Neurosci., 35, 325, 10.1016/j.tins.2012.01.004 · DOI · Paper page
  102. Yamakuchi M., 2008, Proc Natl Acad Sci U S A., 105, 13421, 10.1073/pnas.0801613105 · DOI · Paper page
  103. Dajas-Bailador F., 2012, Nat Neurosci., 15, 697, 10.1038/nn.3082 · DOI · Paper page
  104. Haramati S., 2010, Proc Natl Acad Sci U S A., 107, 13111, 10.1073/pnas.1006151107 · DOI · Paper page
  105. Cohen JE., 2011, Proc Natl Acad Sci U S A., 108, 11650, 10.1073/pnas.1017576108 · DOI · Paper page
  106. Ouyang YB., 2014, Neurosci Lett., 565, 53, 10.1016/j.neulet.2013.11.015 · DOI · Paper page
  107. Wei C., 2013, PLoS One., 8, e57080, 10.1371/journal.pone.0057080 · DOI
  108. Muddashetty RS., 2011, Mol Cell., 42, 673, 10.1016/j.molcel.2011.05.006 · DOI · Paper page
  109. Wibrand K., 2012, PLoS One., 7, e41688, 10.1371/journal.pone.0041688 · DOI · Paper page
  110. Follert P., 2014, Front Mol Neurosci., 7, 5, 10.3389/fnmol.2014.00005 · DOI · Paper page
  111. Garza-Manero S., 2014, Brain Res. In press.
  112. Yao J., 2010, PLoS One., 5, e15546, 10.1371/journal.pone.0015546 · DOI · Paper page
  113. Ji G., 2013, PLoS One., 8, e69351, 10.1371/journal.pone.0069351 · DOI
  114. He M., 2014, Cell Death Dis., 5, e1090, 10.1038/cddis.2014.60 · DOI
  115. Isaya G., 2014, Front Pharmacol., 5, 29, 10.3389/fphar.2014.00029 · DOI · Paper page
  116. Akhter R., 2014, J Biol Chem., 289, 10812, 10.1074/jbc.M113.519355 · DOI · Paper page
  117. Wong HK., 2013, Hum Mol Genet., 22, 3077, 10.1093/hmg/ddt164 · DOI · Paper page
  118. Kole AJ., 2011, Genes Development., 25, 125, 10.1101/gad.1975411 · DOI · Paper page
  119. Truettner JS., 2013, Brain Res., 1533, 122, 10.1016/j.brainres.2013.08.011 · DOI · Paper page
  120. Bonda DJ., 2001, J Alzheimers Dis., 3, 377, 10.3233/JAD-2001-3403 · DOI · Paper page
  121. Seward ME., 2013, J Cell Sci., 126, 1278, 10.1242/jcs.1125880 · DOI · Paper page
  122. Ranganathan S., 2001, J Alzheimers Dis., 3, 377, 10.3233/JAD-2001-3403 · DOI · Paper page
  123. Riba A., 2014, PLoS Comput Biol., 27, e1003490, 10.1371/journal.pcbi.1003490 · DOI
  124. Trompeter HI., 2011, PLoS One., 6, e16138, 10.1371/journal.pone.0016138 · DOI · Paper page
  125. Ueberham U., 2012, Neurobiol Aging., 33, 2827, 10.1016/j.neurobiolaging.2012.01.013 · DOI
  126. Wang H., 2010, Brain Res., 1357, 166, 10.1016/j.brainres.2010.08.023 · DOI
  127. Füllgrabe J., 2014, Nat Rev Mol Cell Biol., 15, 65, 10.1038/nrm3716 · DOI · Paper page
  128. Lee MJ., 2013, Prog Neurobiol., 105, 49, 10.1016/j.pneurobio.2013.03.001 · DOI · Paper page
  129. Fenn AM., 2013, Neurobiol Aging., 34, 2748, 10.1016/j.neurobiolaging.2013.06.007 · DOI · Paper page
  130. Salminen A., 2013, Prog Neurobiol., 106, 33, 10.1016/j.pneurobio.2013.06.002 · DOI · Paper page
  131. Carrettiero DC., 2009, J Neurosci., 29, 2151, 10.1523/JNEUROSCI.4660-08.2009 · DOI · Paper page
  132. Massone S., 2011, Neurobiol Dis., 41, 308, 10.1016/j.nbd.2010.09.019 · DOI · Paper page
  133. Lukiw WJ., 2013, Front Genet., 4, 307
  134. Landry CD., 2013, Trends Neurosci., 36, 535, 10.1016/j.tins.2013.05.004 · DOI
  135. Mus E., 2007, Proc Natl Acad Sci U S A., 104, 10679, 10.1073/pnas.0701532104 · DOI · Paper page
  136. Salta E., 2012, Lancet Neurol., 11, 189, 10.1016/S1474-4422(11)70286-1 · DOI · Paper page
  137. Dorval V., 2013, Front Mol Neurosci., 6, 24
  138. Sheinerman KS., 2013, Front Cell Neurosci., 7, 150, 10.3389/fncel.2013.00150 · DOI · Paper page
  139. Wahlestedt C., 2013, Nat Rev Drug Discov., 12, 433, 10.1038/nrd4018 · DOI · Paper page

Cited by

See all 63

Metadata

Authors
Millan, M. J.
Venue
Dialogues in Clinical Neuroscience
Published
2014-09-30
Volume
16
Issue
3
Pages
373-393
ISSN
  • 1294-8322 (ISSN-L)
  • 1958-5969
OpenAlex
W2156676300
Cited by
63
References
48
FWCI
4.08
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? https://app.cochat.ai/papers/10.31887/dcns.2014.16.3/mmillan
The paper
Millan, M. J. (2014). The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity? Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2014.16.3/mmillan

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.